Navigation

ExploreAnalysisInvestor RelationsAI AssistantCompareScreener
LoginSign Up FreeSign Up
TG

TGTX

Market Closed

TG Therapeutics, Inc.

NASDAQHealthcareBiotechnology
US
399 employees
CEO: Michael S. Weiss
Founded: 2010
$54.78
+$0.00(+NaN%)
Market Cap
8.39B
Beta
1.66
52W Range
N/A
Dividend Yield
0.00%
OverviewForecastsFundamentalMarket SentimentValuationOwnership
OverviewForecastsFundamentalMarket SentimentValuationOwnership
Overall Sentiment
0%
Very Negative
Based on 1 of 3 sources
News
0%
Social
--
Analyst
--
News Media
Overall Score0%
Positive Articles0
Neutral Articles1
Negative Articles0
Total Coverage1 articles
Social Media
No social media data available
Wall Street Analysts
No analyst recommendation data available
Social Sentiment & Market Signals
Real-time social media buzz and conversation analysis

No social sentiment data available

Social media conversation data will appear here once loaded

News Sentiment Risk Analysis
Market sentiment and news coverage impact assessment
Total Articles
1
Avg Sentiment
0.000

Neutral

Positive News
0.0%
Negative News
0.0%

Sentiment Distribution & Risk Assessment

Coverage:Low
Trend:Neutral
Positive
0.0%
Neutral
100.0%
Negative
0.0%
NEUTRALBased on 1 articles

Recent Headlines Impact

No recent news headlines available
Analyst Recommendations
Wall Street analyst consensus and rating distribution

No Analyst Data Available

Analyst recommendations are not available for this stock

Explore TGTX

Overview

Key metrics and AI-powered insights

Forecast

Price targets and earnings estimates

Fundamentals

Income, balance sheet and cash flow

Valuation

P/E, DCF and valuation multiples

Ownership

Institutional and insider holdings

Sentiment

Analyst ratings and news sentiment

TGTX in the Healthcare

Mid Cap
Healthcare

Browse sector stocks →

Biotechnology

Browse industry stocks →

© 2026 MarketCI. All rights reserved.

HelpPricingPrivacyTerms